HomeScreenerSWTXProfile
D
40/100

SpringWorks Therapeutics

SWTXRare Oncology
📋
Analyst Summary
✓ VERIFIED2026-04-11

SpringWorks Therapeutics (SWTX) is the lead sponsor of 6 active clinical trials listed on ClinicalTrials.gov[4], including 2 Phase 2[1], 3 Phase 1[2], 1 Phase 4[3].

No Form 4 insider filings for SWTX were recorded at the SEC in the past 30 days[5].

Sources

  1. ClinicalTrials.gov (2026-04-11)
  2. ClinicalTrials.gov (2026-04-11)
  3. ClinicalTrials.gov (2026-04-11)
  4. ClinicalTrials.gov (2026-04-11)
  5. SEC EDGAR (2026-04-11)
🔬
Clinical Trials
6
NCT03962543Plexiform Neurofibroma, Neurofibromatosis Type 1 (NF1)
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06251310Advanced Solid Tumor, Mesothelioma, Malignant
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06997276Healthy, Hepatic Impairment
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07170644Desmoid Tumor, Aggressive Fibromatosis
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07176689Desmoid Tumor, Aggressive Fibromatosis
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07259330Healthy
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
👤
Insider Activity
1
0 filings
Source ↗
sec_edgar · Retrieved 2026-04-11
Not financial advice. BiotechSigns profiles are AI-generated from verified public sources (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.
Score Breakdown
Score Trend
2026-04-132026-06-02
Signal Summary
PDUFA Dates0
Insider Filings1
Clinical Trials1
Data Provenance
clinical trial6 verified
insider buy1 verified
trial count4 verified
Every claim backed by source URL from ClinicalTrials.gov or SEC EDGAR